Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacological evaluation of antinociceptive and anti-inflammatory activities of LQFM202: a new piperazine derivative.
Martins AN, de Souza Almeida D, Florentino IF, da Silva Moreira LK, Turones LC, Batista DC, Machado LS, Vaz BG, Lião LM, de Almeida Ribeiro Oliveira G, Martins JLR, Fajemiroye JO, Menegatti R, Costa EA, da Silva DPB. Martins AN, et al. Among authors: da silva dpb. Inflammopharmacology. 2023 Feb;31(1):411-422. doi: 10.1007/s10787-022-01103-x. Epub 2022 Nov 29. Inflammopharmacology. 2023. PMID: 36443517
Potential antidepressant-like effect of piperazine derivative LQFM212 in mice: Role of monoaminergic pathway and brain-derived neurotrophic factor.
Moreira LKDS, de Brito AF, da Silva DM, Siqueira L, da Silva DPB, Cardoso CS, Florentino IF, de Carvalho PMG, Ghedini PC, Menegatti R, Costa EA. Moreira LKDS, et al. Among authors: da silva dpb. Behav Brain Res. 2021 Mar 5;401:113066. doi: 10.1016/j.bbr.2020.113066. Epub 2020 Dec 14. Behav Brain Res. 2021. PMID: 33333109
Anti-inflammatory and antinociceptive activity profile of a new lead compound - LQFM219.
Galvão GM, Florentino IF, Sanz G, Vaz BG, Lião LM, Sabino JR, Cardoso CS, da Silva DPB, Costa EA, Silva ALP, da Silva ACG, Valadares MC, Leite JA, de S Gil E, Menegatti R. Galvão GM, et al. Among authors: da silva dpb. Int Immunopharmacol. 2020 Nov;88:106893. doi: 10.1016/j.intimp.2020.106893. Epub 2020 Sep 3. Int Immunopharmacol. 2020. PMID: 32892073
Molecular docking and pharmacological/toxicological assessment of a new compound designed from celecoxib and paracetamol by molecular hybridization.
da Silva DPB, Florentino IF, da Silva DM, Lino RC, Cardoso CS, Moreira LKS, Vasconcelos GA, Vinhal DC, Cardoso ACD, Villavicencio B, Verli H, Vaz BG, Lião LM, da Cunha LC, Menegatti R, Costa EA. da Silva DPB, et al. Inflammopharmacology. 2018 Oct;26(5):1189-1206. doi: 10.1007/s10787-018-0516-7. Epub 2018 Jul 23. Inflammopharmacology. 2018. PMID: 30039481
Tert-butyl 4-((1-phenyl-1H-pyrazol-4-yl) methyl) piperazine-1-carboxylate (LQFM104)- New piperazine derivative with antianxiety and antidepressant-like effects: Putative role of serotonergic system.
da Silva DM, Sanz G, Vaz BG, de Carvalho FS, Lião LM, de Oliveira DR, Moreira LKDS, Cardoso CS, de Brito AF, da Silva DPB, da Rocha FF, Santana IGC, Galdino PM, Costa EA, Menegatti R. da Silva DM, et al. Among authors: da silva dpb. Biomed Pharmacother. 2018 Jul;103:546-552. doi: 10.1016/j.biopha.2018.04.077. Epub 2018 Apr 24. Biomed Pharmacother. 2018. PMID: 29677541
Monoamine Involvement in the Antidepressant-Like Effect of β-Caryophyllene.
de Oliveira DR, da Silva DM, Florentino IF, de Brito AF, Fajemiroye JO, da Silva DPB, da Rocha FF, Costa EA, Galdino PM. de Oliveira DR, et al. Among authors: da silva dpb. CNS Neurol Disord Drug Targets. 2018;17(4):309-320. doi: 10.2174/1871527317666180420150249. CNS Neurol Disord Drug Targets. 2018. PMID: 29676236
Chemical characterization and pharmacological assessment of polysaccharide free, standardized cashew gum extract (Anacardium occidentale L.).
da Silva DPB, Florentino IF, da Silva Moreira LK, Brito AF, Carvalho VV, Rodrigues MF, Vasconcelos GA, Vaz BG, Pereira-Junior MA, Fernandes KF, Costa EA. da Silva DPB, et al. J Ethnopharmacol. 2018 Mar 1;213:395-402. doi: 10.1016/j.jep.2017.11.021. Epub 2017 Nov 21. J Ethnopharmacol. 2018. PMID: 29166575 Free article.
Pharmacological evaluation and molecular docking of new di-tert-butylphenol compound, LQFM-091, a new dual 5-LOX/COX inhibitor.
Lino RC, da Silva DPB, Florentino IF, da Silva DM, Martins JLR, Batista DDC, Leite KCS, Villavicencio B, Vasconcelos GA, Silva ALP, de Ávila RI, Verli H, Valadares MC, Gil ES, Vaz BG, Lião LM, Menegatti R, Costa EA. Lino RC, et al. Among authors: da silva dpb. Eur J Pharm Sci. 2017 Aug 30;106:231-243. doi: 10.1016/j.ejps.2017.06.006. Eur J Pharm Sci. 2017. PMID: 28599988
12 results